BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10994833)

  • 21. Linear immunoglobulin A bullous dermatosis induced by gemcitabine.
    del Pozo J; Martínez W; Yebra-Pimentel MT; Almagro M; Peña-Penabad C; Fonseca E
    Ann Pharmacother; 2001; 35(7-8):891-3. PubMed ID: 11485141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane.
    Gabrielsen TO; Staerfelt F; Thune PO
    Acta Derm Venereol; 1981; 61(5):439-41. PubMed ID: 6172936
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced linear IgA bullous dermatosis probably induced by furosemide.
    Cerottini JP; Ricci C; Guggisberg D; Panizzon RG
    J Am Acad Dermatol; 1999 Jul; 41(1):103-5. PubMed ID: 10411419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced linear IgA disease: target antigens are heterogeneous.
    Paul C; Wolkenstein P; Prost C; Caux F; Rostoker G; Heller M; Wechsler J; Revuz J; Roujeau JC
    Br J Dermatol; 1997 Mar; 136(3):406-11. PubMed ID: 9115927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linear IgA bullous dermatosis. An immunologically defined disease.
    Wilson BD; Beutner EH; Kumar V; Chorzelski TP; Jablonska S
    Int J Dermatol; 1985 Nov; 24(9):569-74. PubMed ID: 3905638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug-induced bullous dermatosis with linear IgA].
    Valsecchi R; Serra M; Tornaghi A; Cainelli T
    G Ital Dermatol Venereol; 1982; 117(4):221-3. PubMed ID: 6764913
    [No Abstract]   [Full Text] [Related]  

  • 28. Generalized linear IgA dermatosis with palmar involvement.
    Norris IN; Haeberle MT; Callen JP; Malone JC
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Linear IgA bullous dermatosis of children].
    Pierchalla A; Bruch-Gerharz D; Homey B; Reifenberger J
    Hautarzt; 2011 Apr; 62(4):262-4. PubMed ID: 21424888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia.
    Arakaki O; Yamamoto Y; Awazawa R; Nonaka K; Taira K; Asato Y; Hagiwara K; Oyama B; Ishii N; Hashimoto T; Uezato H
    J Dermatol; 2008 Jul; 35(7):437-46. PubMed ID: 18705832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium.
    Marzano AV; Ramoni S; Spinelli D; Alessi E; Berti E
    J Dermatolog Treat; 2008; 19(6):364-7. PubMed ID: 19016105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.
    Kuechle MK; Stegemeir E; Maynard B; Gibson LE; Leiferman KM; Peters MS
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):187-92. PubMed ID: 7904616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
    Jones DH; Todd M; Craig TJ
    J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine.
    Yang Z; Liu ZH; Sun CQ; Shen H
    Dermatol Ther; 2020 Mar; 33(2):e13210. PubMed ID: 31895494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
    Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
    Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug induced linear IgA bullous dermatosis].
    Montagnac R; Reguiaï Z; Méhaut S; Bressieux JM; Schillinger F
    Nephrologie; 2003; 24(6):287-92. PubMed ID: 14584295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linear IgA bullous dermatosis mimicking a neutrophilic dermatosis.
    Dietrich N; Beltraminelli H; Borradori L
    Eur J Dermatol; 2012; 22(5):713-4. PubMed ID: 22913880
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells.
    Yawalkar N; Reimers A; Hari Y; Hunziker T; Gerber H; Müller U; Pichler W
    Dermatology; 1999; 199(1):25-30. PubMed ID: 10449953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
    Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
    Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.